Cellebrite DI Ltd.
NASDAQ Global SelectTotal Valuation
Cellebrite DI Ltd. carries a market capitalization of 1.06B, placing it among publicly traded companies globally. Its enterprise value stands at -406.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.06B |
| Enterprise Value | -406.26M |
Share Statistics
Cellebrite DI Ltd. currently has 249.44M shares outstanding.
| Shares Outstanding | 249.44M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Cellebrite DI Ltd. maintains a current ratio of 1.54, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.54 |
| Quick Ratio | 1.43 |
| Debt / Equity | 4.47 |
| Debt / EBITDA | 0.29 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 8.65 |
| Return on Invested Capital (ROIC) | 11.82 |
| Return on Capital Employed (ROCE) | -75.78 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.71 |
Taxes
Over the trailing twelve months, Cellebrite DI Ltd. has paid 13.12M in income taxes, reflecting an effective tax rate of 15.44.
| Income Tax | 13.12M |
| Effective Tax Rate | 15.44 |
Stock Price Statistics
Cellebrite DI Ltd.'s stock has gained approximately 404.67308% over the past 52 weeks. The 50-day moving average sits at - -, while the 200-day moving average is - -.
| Beta (5Y) | N/A |
| 52-Week Price Change | 404.67308% |
| 50-Day Moving Average | - - |
| 200-Day Moving Average | - - |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached 79.57M, while operating income came in at 63.33M.
| Revenue | 496.43M |
| Gross Profit | 416.33M |
| Operating Income | 63.33M |
| Pretax Income | 84.98M |
| Net Income | 71.86M |
| EBITDA | 79.57M |
| EBIT | 63.33M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Cellebrite DI Ltd. holds 429.07M in cash and equivalents against 22.81M in total debt, resulting in a net debt position of -133.69M. Total book value stands at -75.60M, with working capital of 190.66M providing operational flexibility.
| Cash & Cash Equivalents | 429.07M |
| Total Debt | 22.81M |
| Net Debt | -133.69M |
| Equity (Book Value) | -75.60M |
| Book Value Per Share | N/A |
| Working Capital | 190.66M |
Cash Flow
Cellebrite DI Ltd. produced 172.55M in operating cash flow over the past twelve months.
| Operating Cash Flow | 172.55M |
| Capital Expenditures | -20.99M |
| Free Cash Flow | 151.57M |
| FCF Per Share | N/A |
Margins
Cellebrite DI Ltd. operates with a gross margin of 83.86, reflecting its pricing power and cost economics. The operating margin of 12.76 and net profit margin of 14.48 provide insight into operational efficiency.
| Gross Margin | 83.86 |
| Operating Margin | 12.76 |
| Pretax Margin | 17.12 |
| Profit Margin | 14.48 |
| EBITDA Margin | 16.03 |
Scores
Cellebrite DI Ltd. posts an Altman Z-Score of 1.18, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.18 |